Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

7 hrs ago | Benzinga

's Weekend M&A Chatter

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday April 18 through Sunday April 20, 2014.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca, AstraZeneca Group, thePlatform, Cable & Satellite, Comcast

11 hrs ago | This Is Money

Viagra drug firm Pfizer mulls 60bn bid for struggling UK drugs group AstraZeneca

If such a deal were to happen, it would be the biggest-ever foreign takeover this country has seen and would inevitably provoke huge controversy in the wake of Cadbury's sale to Kraft and a string of other sales of British household names to overseas buyers.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

17 hrs ago | Bloomberg

Pfizer Made $101 Billion Bid for AstraZeneca: Sunday Times of London

Pfizer Inc. approached AstraZeneca Plc about acquiring the U.K. drugmaker in a deal that would value the company at more than 60 billion pounds , according to a media report.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Thu Apr 17, 2014

BusinessWeek

U.S. States Target Corporate Cash Stashed Overseas

Members of Congress have complained for years about U.S. corporations that park profits overseas to avoid paying federal taxes.

Comment?

Related Topix: US News, Pfizer, Biotech, Medicine, Healthcare Industry, Maine

BioSpace

Teva Pharmaceutical Industries Limited Settles Patent Litigation With ...

Teva Pharmaceutical Industries Ltd. announced today that its subsidiary Teva Pharmaceuticals USA, Inc. has entered into a settlement with Pfizer related to Teva's generic version of CelebrexA 50, 100, 200 and 400 mg capsules in the United States.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Food and Drug Administration

Sys-Con Media

Innovative Blue Button Project to Be Discussed at DIA 2014 50th Annual Meeting

Craig Lipset, head of clinical innovation at Pfizer Inc., will join advocates of patient data accessibility to highlight the Blue Button initiative at the DIA 2014 50th Annual Meeting in San Diego.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Sys-Con Media

Arch Biopartners Appoints Claude Allary to Board of Directors

Mr. Allary currently is in Paris working as independent consultant and executive coach in life sciences.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

Mon Apr 14, 2014

Freshnews

Bioscience West Map Plots Life Science Industry Growth In California

Silicon Maps, Inc. the leading promotional industry Map design firm for Life Sciences has launched the new BIOSCIENCE WEST Map & Calendar campaign for 2015; the 15 edition depicts a robust industry featuring over 150 companies.

Comment?

Related Topix: California, Marketing, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Johnson & Johnson

Business Wire

View Press Release

AdvilA Relief in Action and Josh Duhamel Celebrate National Volunteer Week with Points of Light & Kick off a Nationwide "Relief" Tour #ReliefinAction reignites in its second year of helping volunteers who don't let pain stop them from helping others with a Mobile Relief Center tour and the #ReliefinAction Pledge )--Pfizer Consumer Healthcare, ... (more)

Comment?

Related Topix: Medicine, Health, Pain, Pfizer, Biotech, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Social Software

The Lebanon Daily News

What cancer's miracle patients can teach us about the disease

Now scientists are starting to use sophisticated DNA sequencing technology to determine if these "exceptional responders" carry gene variations that can lead to new treatment approaches, better targeted therapies or even the re- emergence of experimental drugs once deemed failures.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Memorial SloanKettering Cancer Center, Hospital Administration, Cambridge, MA

Fri Apr 11, 2014

The Charlotte Observer

Book review: "The Divide"

Author and journalist Matt Taibbi speaks to Occupy Wall Street protesters after a march on the New York offices of pharmaceutical giant Pfizer in 2012.

Comment?

Related Topix: Occupy Wall Street, New York, Pfizer, Biotech, Medicine, Healthcare Industry

Thu Apr 10, 2014

GantDaily.com

Acura Pharmaceuticals Inc. ends licensing agreement with Pfizer

New York, NY, United States - Acura Pharmaceuticals Inc. announced on Thursday that it struck a deal to end Pfizer Inc.'s license for its Aversion technology.

Comment?

Related Topix: Medicine, Health, Pain

Mon Apr 07, 2014

The Washington Post

Pfizer Breast Drug Helps Revive Forsaken Cancer Strategy: Health

Pfizer Inc., Eli Lilly & Co. and Novartis AG have dug an idea out of the pharmaceutical dustbin to create new medicines that are showing blockbuster potential against hard-to-treat forms of breast cancer.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Eli Lilly, Eons, Noven Pharmaceuticals, Health, Breast Cancer

Reuters

Us Stocks-Wall St flat as momentum stocks stabilize; Pfizer drags

U.S. stocks were little changed on Monday, as recent weakness in so-called momentum names appeared to abate while a decline in shares of Pfizer weighed on the market.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Financial Markets, Healthcare Industry, Gilead Sciences, Healthcare Law, Law

Sun Apr 06, 2014

Bloomberg

Pfizer, Lilly Breast Cancer Drugs Slow Tumors in Studies

Experimental breast cancer drugs from Pfizer Inc. and Eli Lilly & Co. slowed or halted growth of advanced tumors in studies, potentially adding a new treatment option for patients and top-selling therapies for the companies.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Eli Lilly, US News

The Washington Post

Pfizer, Lilly Drugs Slow Advanced Breast Cancer in Studies

Experimental breast cancer drugs from Pfizer Inc. and Eli Lilly & Co. slowed or halted growth of advanced tumors in studies, potentially adding a new treatment option for patients and top-selling therapies for the companies.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Eli Lilly, Business News

Customer Interaction Solutions

Pfizer's Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole...

Pfizer Inc. today announced detailed results from the PALOMA-1 study, a randomized Phase 2 study of palbociclib in combination with letrozole.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, UC Los Angeles, Healthcare Law, Law

Fri Apr 04, 2014

Pharmaceutical Online

BDP Week Highlights The Importance Of Communication In Pharma

At this year's Biopharmaceutical Development and Production Week, March 24-27 at the Hilton Bayfront Hotel, I attended several sessions that focused on how to strengthen the relationship between partners in the pharmaceutical industry.

Comment?

Related Topix: Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Outsourcing

Thu Apr 03, 2014

GigaOM

Patent reform in peril as trial lawyers flex muscle

Congress was poised to go forward with patent reform this week but an unexpected hold-up in the Senate suggests the process could be in trouble.

Comment?

Related Topix: US News, US Politics, Patrick Leahy, US Senate, Democrat, Charles Schumer

PR-inside.com

Report Published: "Royalty Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile"

Royalty Pharma is a life sciences financing company. The company acquires royalty interests in pharmaceutical and biotechnology products, and holds interests as a part of a diversified portfolio through expiration of the patents.

Comment?

Related Topix: Inventions, Science / Technology, Pfizer, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••